Oncology Clinical Trial Finder
Breast Cancer

Recruiting • Phase NA • Stage 0, I, II, III • Surgical • Post-Menopausal • Brain Metastases absent • Interventional

The following is imported from ClinicalTrials.gov:

A Culturally Sensitive Social Support Intervention

This study is a randomized controlled trial (RCT) to assess the impact of a culturally based social support program (i.e. Joy Luck Academy, JLA) among Chinese American breast cancer survivors.

This study is a randomized controlled trial (RCT) to test the health benefits of an education and peer mentor support intervention. Chinese American breast cancer survivors who have completed primary treatment will be randomly assigned to either the intervention group or a control group to receive enhanced usual care while waiting for the JLA. Health outcomes are assessed at baseline, immediately post intervention, and 1 and 4 months follow-ups.

Breast Cancer

Study Design
Study type:


Estimated enrollment:

168 participant

Actual study start date:

January 20, 2015

Eligibility Criteria
Ages eligible for study:

18 - 999

Sexes eligible for study:


Arms and Intervention
  • Social support intervention

Inclusion criteria
  • self-identified to be comfortable speaking chinese (mandarin or cantonese)

  • having a first breast cancer diagnosis of stages 0-iii

  • having completed primary treatment (surgery, chemotherapy, or radiotherapy) within the last 36 months

Exclusion criteria
  • unable to read or speak chinese (mandarin or cantonese)

  • breast cancer diagnosis of stage iv

  • live outside of the la area

Trial Information at Site
Last Updated:
Trial Information
ClinicalTrial.gov ID:


Estimated Enrollment:


Last Updated:


Site Contact

Alice Loh


Herald Cancer Association

Los Angeles, California, United States, 91776

Trial Contact

Qian Lu, PhD; MD



Lenna Dawkins-Moultin, PhD



Principal Investigator

Qian Lu, PhD; MD

Trial Sponsor

M.D. Anderson Cancer Center

Study Location (1)

Herald Cancer Association

Los Angeles, California, United States


© 2024 Outcomes4Me Inc. All rights reserved.